nifedipine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As hypoxia is a major driver for the pathophysiology of COVID-19, it is crucial to characterize the hypoxic response at the cellular and molecular levels." | 1.62 | FDA approved L-type channel blocker Nifedipine reduces cell death in hypoxic A549 cells through modulation of mitochondrial calcium and superoxide generation. ( Gare, S; Giri, L; Gupta, P; Gupta, RK; Manohar, K; Misra, A; Saha, D; Sarkar, R, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manohar, K | 1 |
| Gupta, RK | 1 |
| Gupta, P | 1 |
| Saha, D | 1 |
| Gare, S | 1 |
| Sarkar, R | 1 |
| Misra, A | 1 |
| Giri, L | 1 |
| Luks, AM | 1 |
| Swenson, ER | 1 |
1 review available for nifedipine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
COVID-19 Lung Injury and High-Altitude Pulmonary Edema. A False Equation with Dangerous Implications.
Topics: Acetazolamide; Altitude Sickness; Betacoronavirus; Carbonic Anhydrase Inhibitors; Coronavirus Infect | 2020 |
1 other study available for nifedipine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
FDA approved L-type channel blocker Nifedipine reduces cell death in hypoxic A549 cells through modulation of mitochondrial calcium and superoxide generation.
Topics: A549 Cells; Calcium; Calcium Channel Blockers; Cell Death; COVID-19; Humans; Hypoxia; Nifedipine; SA | 2021 |